Arcadia vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
Population health and value-based care analytics platform aggregating clinical and claims data for health systems and ACOs. Burlington MA, raised $100M+.
About
Arcadia is a healthcare data and analytics company that helps health systems, ACOs, and payers succeed in value-based care arrangements. Headquartered in Burlington, Massachusetts, and having raised more than $100 million from investors including Andreessen Horowitz, Arcadia's platform aggregates clinical data from EHRs, claims data from payers, and social determinants of health data from community sources into a unified longitudinal patient record. This master data layer powers care management workflows, quality measurement, network analytics, and financial performance reporting for value-based care programs.\n\nArcadia's differentiation lies in its ability to normalize and harmonize data from dozens of disparate EHR and claims sources at scale, giving health system leaders and ACO operators a complete and accurate view of their attributed populations. The platform supports MSSP, Medicare Advantage, commercial value-based contracts, and Medicaid managed care programs, helping organizations track performance against quality metrics like HEDIS and CMS Stars while identifying high-risk members for intervention. Embedded care management tools allow clinical teams to act directly on the insights the platform surfaces.\n\nThe company has positioned itself as a strategic analytics partner for complex, multi-entity health systems that cannot rely on a single EHR vendor for population health insights. Arcadia competes with health IT giants like Health Catalyst and Optum as well as specialty vendors, and has continued to grow its customer base among large regional health systems and national provider organizations participating in risk-bearing contracts.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.